Search

Adaptive Phage Therapeutics (APT), having recently doubled its biologics manufacturing capability (intended for its upcoming phage clinical trials), is currently in talks with a partner to help with rapid production of a COVID-19 vaccine ca

Ella Balasa, one of our guest writers and volunteers, and former phage therapy recipient, has written about what it's like being at high risk for COVID-19; a very sobering read (though it ends on a positive note!).

Gabriel Magno de Freitas Almeida and Lotta-Riina Sundberg (University of Jyvaskyla, Finland) have published a historical review in The Lancet Infectious Diseases that dives into the forgotten history of phage therapy in Brazil. They show th

Michelle Bach (Stanford University) and colleagues published a new preprint on how the filamentous phage Pf (present in 69% of Pseudomonas aeruginosa wounds) delays healing of P. aeruginosa-infected wounds by provoking an anti-phage immune

Przemysław Decewicz (University of Warsaw, Poland) and colleagues have isolated two virulent phages infecting Ochrobactrum spp. for the first time. The host, due to its extensive repertoire of enzymatic properties, is a key player in the bi

Adair Borges and colleagues from the Bondy-Denomy lab at UCSF have published a paper discussing how Pseudomonas aeruginosa host factors, previously characterized for their role in alginate biosynthesis, affect its Type I-F CRISPR–Cas system

Cédric Lood (KU Leuven) and colleagues published a new paper on jumbo phage-host interactions: they used an integrative omics approach (hybrid sequencing, RNAseq, and mass spectrometry) to look at Pseudomonas aeruginosa phage PA5oct and its

Ella Balasa, one of our guest writers and volunteers, and former phage therapy recipient, has written about what it's like being at high risk for COVID-19; a very sobering read (though it ends on a positive note!).

Przemysław Decewicz (University of Warsaw, Poland) and colleagues have isolated two virulent phages infecting Ochrobactrum spp. for the first time. The host, due to its extensive repertoire of enzymatic properties, is a key player in the bi

From Elizabeth McDaniel, via Twitter: There’s a lot of interest right now for learning bioinformatics skills while lab research is suspended and everybody is working from home. I wanted to share free resources for learning coding basics and

From Karen Maxwell, via Twitter: #phage community - which phage is most SARS-CoV2 like? Seems like many assays for inactivation, etc could be widely performed and then translated. Who has stocks???

Cédric Lood (KU Leuven) and colleagues published a new paper on jumbo phage-host interactions: they used an integrative omics approach (hybrid sequencing, RNAseq, and mass spectrometry) to look at Pseudomonas aeruginosa phage PA5oct and its

On account of the current situation of worldwide spreading coronavirus SARS-CoV2, the organising committee might have to consider post-postponing Viruses of Microbes 2020, initially planned to take place on the 13-17 July. However, due to t

Phage Directory has three new volunteers! Please welcome Lauren Dunlop, Dr. Rohit Kongari and Lizzie Richardson! Lauren helps us behind the scenes with things like finding out about grants we can apply for. Rohit and Lizzie are currently he

Merry Youle, author of Thinking Like A Phage, Life in our Phage World, blogger emerita for Small Things Considered, and beloved member of the phage community, has sadly passed away.

Dr. Minmin Yen, PhagePro We're looking to explore the whole ecosystem of diarrheal disease prevention in low- and middle-income countries through short video interviews. We would particularly welcome those who are working on developing phag

We have a cow we suspect has Johne's disease (Mycobacterium avium paratuberculosis infection). Does anyone have phages for this bacteria that might also infect M. smegmatis? Currently, there is no treatment; vaccine was discontinued in US a

Jeremy Barr, Monash University Hello everyone, due to the COVID-19 situation we will be postponing the Monash-UCSD Bacteriophage Symposium that was to be held in Melbourne on the 30th of March. We will instead explore online options and wil

The Cystic Fibrosis Foundation announced they will provide up to $5M to support Armata Pharmaceuticals in conducting a Phase 1b/2 clinical trial to test the safety and tolerability of phage therapy in Pseudomonas aeruginosa infections in pe

Germán Bonilla-Rosso (University of Lausanne, Switzerland) and colleagues published a new paper in PNAS on the honey bee gut virome. They show that a diverse community of phages inhabits the bee gut, that these phages target core bee gut ba